Pharmafile Logo

Research Partnership publishes 2016 Living with RA reports

July 6, 2016 | rheumatoid arthritis 

Research Partnership has published new Living with rheumatoid arthritis (RA) EU and US market reports for 2016.

Living with RA is a quantitative study conducted online amongst 500 patients diagnosed with rheumatoid arthritis in 5 EU markets (France, Germany, Italy, Spain and the UK) and 500 patients in the US. The findings have been analysed and the resulting insights compiled in two comprehensive graphical reports which are now available to buy.

The reports are intended to help pharmaceutical companies with products in this disease area get a deeper understanding of patient attitudes, behaviours and future needs, as well as understand patient relationships with healthcare professionals and their current treatment programmes, including biologic and biosimilar use. 

http://www.researchpartnership.com/news/2016/06/news-living-with-ra-reports-published/

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Webcast: AI in MRX: Harnessing the power of AI + people

Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.

Product launch: What market research when?

Get the insights you need, when you need them, for your product launch planning

Therapy Watch launches new tracker covering Alzheimer’s Disease

The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.

Therapy Watch launches new tracker covering pulmonary arterial hypertension (PAH)

Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.

Healthcare in the age of AI: How will artificial intelligence impact future decision-making?

Authored by: Constanza Salas, Jhon Galindo and Rachel Howard

Therapy Watch launches new tracker covering Postpartum Depression

The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry

Infographic: Rare Diseases in China

How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.